Clare Griffin

Institute of Cancer Research — United Kingdom

Medicine · Health Sciences

30h-index5.9kcitations101works18.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(39), Prostate Cancer Diagnosis and Treatment(38), Advanced Radiotherapy Techniques(25), Breast Cancer Treatment Studies(18), Bladder and Urothelial Cancer Treatments(11)

Publications101 total

Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5 years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials
Radiotherapy and Oncology·2025Open Access
Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial
Radiotherapy and Oncology·2025· 3 citedOpen Access
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
The Lancet Oncology·2025· 20 citedOpen Access
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial
The Lancet Oncology·2025· 11 citedOpen Access
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study
Radiotherapy and Oncology·2025· 9 citedOpen Access
5025 Hypofractionated breast radiotherapy for 1 week vs 3 weeks: 10-year efficacy and late normal tissue effects in the FAST-Forward randomised trial
Radiotherapy and Oncology·2025· 5 cited
Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancers
British Journal of Radiology·2025· 1 cited
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
New England Journal of Medicine·2024· 174 citedOpen Access
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial
European Urology·2024· 18 citedOpen Access
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
European Urology·2024· 47 citedOpen Access
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer
Radiotherapy and Oncology·2024· 4 citedOpen Access
Abstract PS04-04: Adverse effects (AEs) reported via Patient Reported Outcome Measures (PROMs): A longitudinal analysis of the IMPORT HIGH breast radiotherapy trial (CRUK/06/003)
Cancer Research·2024
Abstract PO5-22-04: Genomic analysis of local recurrences following risk adapted breast radiotherapy in the IMPORT trials defines 'true recurrences' and 'new primaries'
Cancer Research·2024· 1 cited
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply
The Lancet·2024· 1 citedOpen Access
1221: Using routinely collected data for long term toxicity assessment; a case-study from the CHHiP trial
Radiotherapy and Oncology·2024
3395: Acute toxicity from PACE-C comparing Stereotactic Body Radiotherapy (SBRT) with moderate hypofractionation (MHRT)
Radiotherapy and Oncology·2024· 3 cited
Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003)
International Journal of Radiation Oncology*Biology*Physics·2023· 1 cited
5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2023· 49 cited
International Society of Urological Pathology ( <scp>ISUP)</scp> Gleason Grade Groups stratify outcomes in the <scp>CHHiP</scp> Phase 3 prostate radiotherapy trial
British Journal of Urology·2023· 2 citedOpen Access
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial
The Lancet·2023· 92 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Emma Hall(28), Isabel Syndikus(19), John Staffurth(15), Olivia Naismith(15), Christopher Scrase(13), David P. Dearnaley(12), Clare Cruickshank(12), Vincent Khoo(10), Alison Birtle(10), Alison Tree(10), Miguel Panades(9), Joanne Haviland(9), John Yarnold(9), Judith M. Bliss(9), Helen Mayles(8), Stephanie Brown(8), H. McNair(8), Ananya Choudhury(8), Shama Hassan(7), Julia Pugh(7)